Skip to content

Feasibility study of physiological signals for assessment of radiotherapy effects in lung cancer patients

Feasibility study of physiological signals for assessment of radiotherapy effects in lung cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069713
Enrollment
Unknown
Registered
2023-03-23
Start date
2022-05-11
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Control group:No

Sponsors

Army and Military Medical University of the PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Lung space-occupying lesions were found by imaging examination, and lung cancer was confirmed by histopathological examination; 2. Age between 18-75; 3. ECOGPS score 0~1; 4. Measurable or evaluable lesions; 5. No radiotherapy contraindications; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, liver and kidney insufficiency; 2. Patients with acute infectious diseases; 3. The same lesion has undergone radiotherapy; 4. Those who have not completed the treatment; 5. Those with incomplete clinical data; 6. Cannot cooperate with the research for any reason or the researcher thinks it is not suitable to be included in this trial.

Design outcomes

Primary

MeasureTime frame
HRV (Heart rate variability);Respiratory impedance;Diaphragm electrical signal;

Secondary

MeasureTime frame
Dosimetric index;Toxic side reactions;

Countries

China

Contacts

Public ContactXiaojuan Duan

Second Affilicted Hospital of Army Medical University, PLA

seraphic_dxj@163.com+86 173 1841 2840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026